Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
July 25, 2023
0Patent Application Number
165997090
Date Filed
October 11, 2019
0Patent Citations
Patent Primary Examiner
CPC Code
IL33 antagonists alone or in combination with IL-4R antagonists can be used to treat or inhibit eosinophilic asthma, eosinophilic COPD, eosinophilic ACOS, and nasal polyps in a subject having one or more risk alleles in the intronic IL1RL1 variant rs1420101, in the IL33 variant rs1342326, in both, or in variants in linkage disequilibrium thereof.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.